43 results on '"Karamboulas, Christina"'
Search Results
2. PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma
3. Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma
4. Supplementary Figure 6 from PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma
5. Supplementary Figure 3 from PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma
6. Supplementary Figure 7 from PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma
7. Supplementary Figure 4 from PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma
8. Supplementary Data from PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma
9. Supplementary Figure 1 from PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma
10. Supplementary Figure 2 from PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma
11. Supplementary Figure 5 from PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma
12. Role of microRNA-dependent PTEN downregulation in the resistance to PI3K inhibitor alpelisib in head & neck squamous cell carcinoma
13. RNA Processing and Translation
14. Extracellular Heparan 6-O-Endosulfatases SULF1 and SULF2 in Head and Neck Squamous Cell Carcinoma and Other Malignancies
15. Developmental signaling pathways in cancer stem cells of solid tumors
16. Extracellular heparan 6-O-endosulfatases SULF1 and SULF2 in HNSC and other malignancies
17. Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment
18. 45: Patient-Derived Xenograft Engraftment Predicts Oral Cavity Cancer Outcomes
19. Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement
20. Gli2 and MEF2C activate each otherʼs expression and function synergistically during cardiomyogenesis in vitro
21. Abstract IA02: Utilizing patient-derived xenografts for prognostication and biomarker discovery
22. PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma
23. Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma
24. Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21
25. Factors in serum regulate Nkx2.5 and MEF2C function
26. Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative β-catenin
27. BMP signaling regulates Nkx2-5 activity during cardiomyogenesis
28. Patient-derived xenografts: a promising resource for preclinical cancer research
29. Abstract 1033: Patient-derived xenografts for prognostication and personalized treatment for head and neck squamous cell carcinoma
30. Abstract 08: Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas
31. Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas
32. Abstract B08: Patient-derived xenografts of oral squamous cell carcinoma: A model system for the identification of prognostic molecular signatures and for preclinical assessment of targeted therapies
33. Tumor-Initiating Cells Are Rare in Many Human Tumors
34. Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state
35. CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma
36. Abstract B47: Characterization of carcinoma-associated fibroblasts from head and neck squamous cell carcinoma
37. Cancer stem cells in head and neck squamous cell carcinoma
38. Gli2 and MEF2C activate each other's expression and function synergistically during cardiomyogenesis in vitro
39. Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative β-catenin
40. Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis
41. HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage
42. Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis
43. Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.